|
RRM2B expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.043260E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.560700E-03 |
| Normal-vs-Stage2 |
9.800200E-02 |
| Normal-vs-Stage3 |
1.322270E-03 |
| Normal-vs-Stage4 |
3.51219999999985E-05 |
| Stage1-vs-Stage2 |
5.484000E-01 |
| Stage1-vs-Stage3 |
3.062000E-01 |
| Stage1-vs-Stage4 |
4.938400E-03 |
| Stage2-vs-Stage3 |
2.735200E-01 |
| Stage2-vs-Stage4 |
4.690300E-02 |
| Stage3-vs-Stage4 |
1.738840E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.356910E-03 |
| Normal-vs-AfricanAmerican |
1.017620E-04 |
| Normal-vs-Asian |
4.080000E-01 |
| Caucasian-vs-AfricanAmerican |
6.033700E-02 |
| Caucasian-vs-Asian |
6.630600E-01 |
| AfricanAmerican-vs-Asian |
2.107800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.998200E-04 |
| Normal-vs-Female |
3.198700E-03 |
| Male-vs-Female |
4.285200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.028110E-04 |
| Normal-vs-Age(41-60Yrs) |
2.935600E-03 |
| Normal-vs-Age(61-80Yrs) |
9.750000E-04 |
| Normal-vs-Age(81-100Yrs) |
5.424100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.328200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.245900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.098840E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.291600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.763200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.539400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.096610E-01 |
| Normal-vs-Grade 2 |
1.597920E-02 |
| Normal-vs-Grade 3 |
2.408500E-04 |
| Normal-vs-Grade 4 |
1.71519999999648E-05 |
| Grade 1-vs-Grade 2 |
9.511600E-01 |
| Grade 1-vs-Grade 3 |
2.582600E-01 |
| Grade 1-vs-Grade 4 |
4.314100E-02 |
| Grade 2-vs-Grade 3 |
1.444250E-02 |
| Grade 2-vs-Grade 4 |
3.161700E-04 |
| Grade 3-vs-Grade 4 |
9.811700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
8.142200E-03 |
| Normal-vs-ccB subtype |
6.999400E-03 |
| ccA subtype-vs-ccB subtype |
8.545800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.660300E-03 |
| Normal-vs-N1 |
2.000200E-01 |
| N0-vs-N1 |
8.099200E-01 |
|
|
